Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2026 Filed Mar 3, 2026 21:21 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 4,075 | $0.00 Strike: $115.67 | $0.00 |
DisclosureSEC source: 0000200406-26-000048 · wk-form4_1772572907.xml · derivative · entry 5 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,075 shares Expires 2027-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:21 UTC |
Decker Robert JVP Corporate Controller
|
SaleCommon Stock | 4,075 | $247.87 | $1,010,070.25 |
DisclosureSEC source: 0000200406-26-000048 · wk-form4_1772572907.xml · nonDerivative · entry 2 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,682 Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:21 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionCommon Stock | 4,075 | $115.67 | $471,355.25 |
DisclosureSEC source: 0000200406-26-000048 · wk-form4_1772572907.xml · nonDerivative · entry 1 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 22:20 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
SaleCommon Stock | 1,322 | $245.66 | $324,762.52 |
DisclosureSEC source: 0000200406-26-000046 · wk-form4_1771885218.xml · nonDerivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,447 Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:11 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 8,998 | $0.00 Strike: $129.51 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 22 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,998 shares Expires 2028-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:11 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 13,625 | $0.00 Strike: $115.67 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 21 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,625 shares Expires 2027-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:11 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
SaleCommon Stock | 8,998 | $244.53 | $2,200,280.94 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 12 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,769 Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:11 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionCommon Stock | 8,998 | $129.51 | $1,165,330.98 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 11 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:11 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
SaleCommon Stock | 13,625 | $244.20 | $3,327,225.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 10 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,769 F7 · price: This transaction was executed in multiple trades at prices ranging from $244.20 to $244.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:11 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionCommon Stock | 13,625 | $115.67 | $1,576,003.75 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 9 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:11 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
SaleCommon Stock | 6,197 | $243.39 | $1,508,287.83 |
DisclosureSEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · nonDerivative · entry 9 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,003 F7 · price: This transaction was executed in multiple trades at prices ranging from $243.39 to $243.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 29,927 | $0.00 Strike: $156.15 | $0.00 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · derivative · entry 15 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,854 Underlying: Common Stock · 29,927 shares Expires 2035-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 21,721 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · derivative · entry 14 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,721 Underlying: Common Stock · 21,721 shares Expires 2034-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
SaleCommon Stock | 2,283 | $243.00 | $554,769.00 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · nonDerivative · entry 9 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,658 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
SaleCommon Stock | 29,927 | $243.00 | $7,272,261.00 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · nonDerivative · entry 8 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,941 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
Exercise / conversionCommon Stock | 29,927 | $156.15 | $4,673,101.05 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · nonDerivative · entry 7 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
SaleCommon Stock | 21,721 | $243.00 | $5,278,203.00 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · nonDerivative · entry 6 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,941 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
Exercise / conversionCommon Stock | 21,721 | $157.92 | $3,430,180.32 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · nonDerivative · entry 5 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,662 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 33,386 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · derivative · entry 26 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,386 shares Expires 2029-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F16 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 12,066 | $0.00 Strike: $129.51 | $0.00 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · derivative · entry 25 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,066 shares Expires 2028-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F16 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 19,241 | $0.00 Strike: $115.67 | $0.00 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · derivative · entry 24 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,241 shares Expires 2027-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F16 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
SaleCommon Stock | 24,961 | $242.68 | $6,057,535.48 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 15 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 F10 · price: This transaction was executed in multiple trades at prices ranging from $242.59 to $242.815. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
SaleCommon Stock | 33,386 | $242.75 | $8,104,451.50 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 14 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,961 F9 · price: This transaction was executed in multiple trades at prices ranging from $242.71 to $242.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 33,386 | $131.94 | $4,404,948.84 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 13 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
SaleCommon Stock | 12,066 | $242.87 | $2,930,469.42 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 12 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,961 F8 · price: This transaction was executed in multiple trades at prices ranging from $242.85 to $242.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 12,066 | $129.51 | $1,562,667.66 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 11 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
SaleCommon Stock | 19,241 | $242.99 | $4,675,370.59 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 10 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,961 F7 · price: This transaction was executed in multiple trades at prices ranging from $242.94 to $243.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 19,241 | $115.67 | $2,225,606.47 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 9 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
Swanson James D.EVP, CIO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 20,521 | $0.00 Strike: $164.62 | $0.00 |
DisclosureSEC source: 0000200406-26-000044 · wk-form4_1771467149.xml · derivative · entry 23 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,521 shares Expires 2031-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vested and was exercisable on the third anniversary of the grant date. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
Swanson James D.EVP, CIO
|
SaleCommon Stock | 20,521 | $242.70 | $4,980,446.70 |
DisclosureSEC source: 0000200406-26-000044 · wk-form4_1771467149.xml · nonDerivative · entry 14 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,698.131 F9 · price: This transaction was executed in multiple trades at prices ranging from $242.69 to $242.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 02:12 UTC |
Swanson James D.EVP, CIO
|
Exercise / conversionCommon Stock | 20,521 | $164.62 | $3,378,167.02 |
DisclosureSEC source: 0000200406-26-000044 · wk-form4_1771467149.xml · nonDerivative · entry 13 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,219.131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
GrantRestricted Share Units · Derivative | 1,034 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · derivative · entry 15 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,034 Underlying: Common Stock · 1,034 shares Expires not disclosed F10 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F10 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F10 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F11 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 14,405 | $0.00 Strike: $243.45 | $0.00 |
DisclosureSEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · derivative · entry 14 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,405 Underlying: Common Stock · 14,405 shares Expires 2036-02-15 F9 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Exercise / conversionRestricted Share Units · Derivative | 526 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · derivative · entry 13 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,050 Underlying: Common Stock · 526 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F8 · balance_after: Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Exercise / conversionRestricted Share Units · Derivative | 492 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · derivative · entry 12 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 491 Underlying: Common Stock · 492 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F8 · balance_after: Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Tax withholdingCommon Stock | 270 | $243.45 | $65,731.50 |
DisclosureSEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · nonDerivative · entry 8 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,200 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Exercise / conversionCommon Stock | 526 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · nonDerivative · entry 7 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Tax withholdingCommon Stock | 252 | $243.45 | $61,349.40 |
DisclosureSEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · nonDerivative · entry 6 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,944 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Exercise / conversionCommon Stock | 492 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000034 · wk-form4_1771467088.xml · nonDerivative · entry 5 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
GrantRestricted Share Units · Derivative | 9,459 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · derivative · entry 16 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,459 Underlying: Common Stock · 9,459 shares Expires not disclosed F10 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F10 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F10 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F8 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 131,734 | $0.00 Strike: $243.45 | $0.00 |
DisclosureSEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · derivative · entry 15 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,734 Underlying: Common Stock · 131,734 shares Expires 2036-02-15 F9 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionRestricted Share Units · Derivative | 4,505 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · derivative · entry 14 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,008 Underlying: Common Stock · 4,505 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F8 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionRestricted Share Units · Derivative | 3,682 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · derivative · entry 13 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,682 Underlying: Common Stock · 3,682 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F8 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Tax withholdingCommon Stock | 1,960 | $243.45 | $477,162.00 |
DisclosureSEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · nonDerivative · entry 8 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 324,447 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionCommon Stock | 4,505 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · nonDerivative · entry 7 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Tax withholdingCommon Stock | 1,602 | $243.45 | $390,006.90 |
DisclosureSEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · nonDerivative · entry 6 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 321,902 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionCommon Stock | 3,682 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000035 · wk-form4_1771467094.xml · nonDerivative · entry 5 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
GrantRestricted Share Units · Derivative | 2,548 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 20 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,548 Underlying: Common Stock · 2,548 shares Expires not disclosed F12 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F12 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F12 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F10 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 35,489 | $0.00 Strike: $243.45 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 19 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,489 Underlying: Common Stock · 35,489 shares Expires 2036-02-15 F11 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionRestricted Share Units · Derivative | 1,026 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 18 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,051 Underlying: Common Stock · 1,026 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F10 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.